Artificial intelligence is transforming neonatal intensive care by enabling a shift from reactive treatment to proactive, precision-based management. Machine learning and deep learning techniques can identify subtle patterns in continuously monitored data that may not be apparent through conventional clinical assessment. AI-assisted models have shown potential in the early prediction of neonatal sepsis, respiratory deterioration, intraventricular hemorrhage, necrotizing enterocolitis, retinopathy of prematurity, and adverse neurodevelopmental outcomes. These tools can assist clinicians in risk stratification, optimize ventilator settings, support interpretation of medical images, and improve resource utilization within the NICU. Despite these advances, widespread implementation remains limited by challenges such as data quality, algorithm bias, lack of external validation, limited interpretability, and concerns regarding patient privacy, ethical governance, and regulatory oversight. AI should therefore be viewed as a clinical decision-support system rather than a replacement for experienced healthcare professionals. Successful integration requires high-quality multicenter datasets, transparent model development, continuous performance monitoring, and collaboration among neonatologists, data scientists, engineers, and policymakers. As evidence continues to grow, AI has the potential to enhance diagnostic accuracy, facilitate earlier interventions, reduce complications, and improve both short- and long-term neonatal outcomes. Thoughtful adoption of these technologies can help redefine neonatal intensive care by delivering safer, more personalized, and evidence-driven care for vulnerable newborns.